HypertensionThe 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapyLes recommandations 2007 du Programme d’éducation canadien sur l’hypertension pour la prise en charge de l’hypertension artérielle : 2e partie – le traitement☆,☆
References (43)
- et al.
Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: A global and regional analysis on reduction of cardiovascular disease risk
Lancet
(2003) - et al.
INTERHEART Study Investigators Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study
Lancet
(2004) - et al.
Blood pressure, stroke, and coronary heart disease Part 1, Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
Lancet
(1990) - et al.
Effects of dietary saturated, monounsaturated, and n-3 fatty acids on blood pressure in healthy subjects
Am J Clin Nutr
(2006) - et al.
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial
Lancet
(2004) - et al.
Active-control equivalence trials and antihypertensive agents
Am J Med
(2001) - et al.
Improvement in medical risk factors and quality of life in women and men with coronary artery disease in the Multicenter Lifestyle Demonstration Project
Am J Cardiol
(2003) - et al.
Effect of potassium-enriched salt on cardiovascular mortality and medical expenses of elderly men
Am J Clin Nutr
(2006) - et al.
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
Lancet
(2002) - et al.
Proteinuria predicting outcome in renal disease: Nondiabetic nephropathies (REIN)
Kidney Int Suppl
(2004)
Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): A randomised controlled trial
Lancet
(2003)
Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus
J Am Coll Cardiol
(2006)
Canadian Hypertension Education Program. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II – therapy
Can J Cardiol
(2006)
ASCOT investigators Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial
Lancet
(2003)
Implications of the INTERSALT study
Hypertension
(1991)
Effects of protein, mono-unsaturated fat, and carbohydrate intake on blood pressure and serum lipids
JAMA
(2005)
Effect of soybean protein on blood pressure: A randomized, controlled trial
Ann Intern Med
(2005)
GA. Effect of longer-term modest salt reduction on blood pressure
Cochrane Database Syst Rev
(2004)
The Felodipine Event Reduction (FEVER) Study: A randomized long-term placebo-controlled trial in Chinese hypertensive patients
J Hypertens
(2005)
Lifestyle changes that reduce blood pressure: Implementation in clinical practice
J Clin Hypertens (Greenwich)
(1999)
Cited by (76)
Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children
2018, Canadian Journal of CardiologyHypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults
2017, Canadian Journal of CardiologyThe 2014 Canadian hypertension education program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
2014, Canadian Journal of CardiologyCitation Excerpt :This document outlines all recommendations endorsed by the CHEP RTF and contains detailed discussion of the evidence base and rationale for recommendations that have been updated or newly added for 2014. Discussion of the rationale for recommendations that remain unchanged is available in previous publications.7-28 A full set of supplementary tables are available as an online supplement to this article.
Risk stratification of resistant hypertension in chronic kidney disease
2013, Journal of the American College of Cardiology
- ☆
for reprints, go to<www.hypertension.ca>.
- ☆
Full text of this paper is also available at. <www.pulsus.com/cardiol/23_07/Pdf/10281_khan.pdf>.
Copyright © 2007 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.